Richton Kathleen P.
Transaction: 07/16/2026
OTHER
Change
+45,000
Price
$7.39
Filing
07/22/2026
Type
OTHER
enGene Holdings Inc.
ENGN • Biotechnology
$1.68
— 0.00 (0.00%)
EarningsLatest report: Jul 31, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$116.81M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.19Healthy liquidity · 6.3Weak profitability
Financial data as of: Jul 31, 2026, 12:00 AM UTCLast earnings update: Jul 31, 2026, 12:00 AM UTCLast profile update: Sep 16, 2026, 12:06 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$1.68
Change0.00%
Shares Out69.73M
Market Cap$116.81M
Enterprise Value$-141.60M
52W Range1.40 - 12.25
Beta-0.27
P/E-23.82
P/B0.51
P/FCF-1.12
EV/EBITDA2.21
EV/FCF1.36
Price$1.68
Change0.00%
Shares Out69.73M
Market Cap$116.81M
Enterprise Value$-141.60M
52W Range1.40 - 12.25
Beta-0.27
P/E-23.82
P/B0.51
P/FCF-1.12
EV/EBITDA2.21
EV/FCF1.36
Earnings Yield-4.20%
FCF Yield-89.03%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.19
Current Ratio6.30
Quick Ratio6.30
Target$3.00
Target Upside79.10%
Target Median$3.00
Target Range2.00 - 4.00
Volume618.70K
Avg Volume1.49M
EPS Surprise0.05
Investment DNA
How strong this company looks for long-term investors
46
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
85/100
Why this score▼
Manageable debt level · 0.19Healthy liquidity · 6.3Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 9 analyst votes · 2026-10-20
61/100
Neutral
Bullish
3
Hold
5
Bearish
1
Price Target
2026-09-16
Low
$2.00
Mean
$3.00
Median
$3.00
High
$4.00
Insider Transactions
Recent executive and insider activity
Richton Kathleen P.
Transaction: 07/16/2026
OTHER
Change
0
Price
Not reported
Filing
07/22/2026
Type
OTHER
Chinoporos Constantine
Transaction: 07/16/2026
OTHER
Change
+75,000
Price
$1.75
Filing
07/22/2026
Type
OTHER
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Richton Kathleen P. | OTHER | +45,000 | $7.39 | 07/16/2026 | 07/22/2026 |
| Richton Kathleen P. | OTHER | 0 | Not reported | 07/16/2026 | 07/22/2026 |
| Chinoporos Constantine | OTHER | +75,000 | $1.75 | 07/16/2026 | 07/22/2026 |
| Zoth Lota S. | BUY | +31,000 | $1.75 | 06/16/2026 | 06/17/2026 |
| Joustra Wouter | BUY | +31,000 | $1.75 | 06/16/2026 | 06/17/2026 |
| Heffernan Michael Thomas | BUY | +31,000 | $1.75 | 06/16/2026 | 06/17/2026 |
| HASTINGS PAUL J | BUY | +31,000 | $1.75 | 06/16/2026 | 06/17/2026 |
| Grossman William | BUY | +31,000 | $1.75 | 06/16/2026 | 06/17/2026 |
| Glickman Richard M | BUY | +31,000 | $1.75 | 06/16/2026 | 06/17/2026 |
| BRUNK GERALD A | BUY | +31,000 | $1.75 | 06/16/2026 | 06/17/2026 |
| Astley-Sparke Philip | BUY | +31,000 | $1.75 | 06/16/2026 | 06/17/2026 |
| Buck Jill | BUY | +195,000 | $9.53 | 01/30/2026 | 02/03/2026 |
| Boyd Matthew Ross | BUY | +195,000 | $9.53 | 01/30/2026 | 02/03/2026 |
| Connolly Joan | BUY | +195,000 | $9.53 | 01/30/2026 | 02/03/2026 |
| Cooper Ronald Harold Wilfred | BUY | +801,000 | $9.53 | 01/30/2026 | 02/03/2026 |
| Daws D. Ryan | BUY | +220,000 | $9.53 | 01/30/2026 | 02/03/2026 |
| Nichols Alexander Julian | BUY | +195,000 | $9.53 | 01/30/2026 | 02/03/2026 |
| Giguere Lee | BUY | +195,000 | $9.53 | 01/30/2026 | 02/03/2026 |
| CHEUNG ANTHONY TZEYEW | BUY | +195,000 | $9.53 | 01/30/2026 | 02/03/2026 |
| Sweiti Hussein | BUY | +600,000 | $6.83 | 09/30/2025 | 10/01/2025 |